Assaying FLT3 variant allele frequency in AML to determine response to treatment
Dual FLT3/SYK oral inhibitor for AML: TAK-659
Looking beyond the leukemic cell for answers
Christopher Pepper et al.
iwAL 2018 day 1 discussion: treatment strategies in pediatric and adult ALL
Charles Mullighan et al.
EBMT 2017: Highlighting the hottest topics in the field of transplantation